Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Ig heavy chain V-II pseudogene** is a segment of DNA highly homologous to functional immunoglobulin heavy chain variable region genes but has lost the ability to encode a functional protein due to disabling mutations such as premature stop codons or frameshifts[4][2]. Pseudogenes like this one are considered 'genomic fossils'—remnants of genes that may have had a function in ancestral species or earlier evolutionary stages, but are non-functional in modern humans[4][2]. They are not typically therapeutic targets as they lack protein expression and function and do not have known disease associations or drug interactions. While some pseudogenes can play regulatory roles at the RNA level (such as acting as microRNA sponges or generating non-coding RNAs with regulatory effects), for this specific pseudogene, no such function has been confirmed[8]. As a pseudogene of an immunoglobulin heavy chain variable region, it is catalogued mainly for genomic annotation, not for use as a drug target or disease biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy chain variable region V-II pseudogene.